» Articles » PMID: 38666544

Cell Death‑related Molecules and Targets in the Progression of Urolithiasis (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2024 Apr 26
PMID 38666544
Authors
Affiliations
Soon will be listed here.
Abstract

Urolithiasis is a high‑incidence disease caused by calcium oxalate (mainly), uric acid, calcium phosphate, struvite, apatite, cystine and other stones. The development of kidney stones is closely related to renal tubule cell damage and crystal adhesion and aggregation. Cell death, comprising the core steps of cell damage, can be classified into various types (i.e., apoptosis, ferroptosis, necroptosis and pyroptosis). Different crystal types, concentrations, morphologies and sizes cause tubular cell damage via the regulation of different forms of cell death. Oxidative stress caused by high oxalate or crystal concentrations is considered to be a precursor to a variety of types of cell death. In addition, complex crosstalk exists among numerous signaling pathways and their key molecules in various types of cell death. Urolithiasis is considered a metabolic disorder, and tricarboxylic acid cycle‑related molecules, such as citrate and succinate, are closely related to cell death and the inhibition of stone development. However, a literature review of the associations between kidney stone development, metabolism and various types of cell death is currently lacking, at least to the best of our knowledge. Thus, the present review summarizes the major advances in the understanding of regulated cell death and urolithiasis progression.

Citing Articles

Comparison of Endoplasmic Reticulum Stress and Pyroptosis Induced by Pathogenic Calcium Oxalate Monohydrate and Physiologic Calcium Oxalate Dihydrate Crystals in HK-2 Cells: Insights into Kidney Stone Formation.

Nong W, Tong X, Ouyang J Cells. 2025; 13(24.

PMID: 39768161 PMC: 11674083. DOI: 10.3390/cells13242070.


Association between the Fatty Liver Index, Metabolic Dysfunction-Associated Steatotic Liver Disease, and the Risk of Kidney Stones.

Zhang F, Li W Kidney Blood Press Res. 2025; 50(1):115-130.

PMID: 39746337 PMC: 11844708. DOI: 10.1159/000543404.

References
1.
Ye Q, Wang D, Wang X, Zhang Z, Tian Q, Feng S . Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem Biol Interact. 2021; 347:109605. DOI: 10.1016/j.cbi.2021.109605. View

2.
Hao W, Zhang H, Hong P, Zhang X, Zhao X, Ma L . Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease. Cell Death Dis. 2023; 14(10):680. PMC: 10575931. DOI: 10.1038/s41419-023-06185-1. View

3.
Gan X, Wang Z, Xu H . Mechanism of miRNA-141-3p in Calcium Oxalate-Induced Renal Tubular Epithelial Cell Injury via NLRP3-Mediated Pyroptosis. Kidney Blood Press Res. 2022; 47(5):300-308. DOI: 10.1159/000521795. View

4.
Bayir H, Dixon S, Tyurina Y, Kellum J, Kagan V . Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023; 19(5):315-336. DOI: 10.1038/s41581-023-00689-x. View

5.
Liu B, Tang T, Lv L, Lan H . Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018; 93(3):568-579. DOI: 10.1016/j.kint.2017.09.033. View